9885.HK
Price:
$6.47
Market Cap:
$3.99B
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. It develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. The company also engages in the wholesale and retail of pharmaceutical and healthcare products. In addition, it provides medical testing services. The company was founded in 2015 and is headquartered in Guangzhou, China.
Industry
IPO Date
2023-06-28
Stock Exchange
HKSE
Ticker
9885.HK
According to YSB Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 46.21. This represents a change of 13.93% compared to the average of 40.56 of the last 4 quarters.
The mean historical PE Ratio of YSB Inc. over the last ten years is 20.77. The current 46.21 PE Ratio has changed 22.15% with respect to the historical average. Over the past ten years (40 quarters), 9885.HK's PE Ratio was at its highest in in the December 2024 quarter at 105.64. The PE Ratio was at its lowest in in the December 2023 quarter at -23.76.
Average
20.77
Median
-1.56
Minimum
-4.29
Maximum
114.48
Discovering the peaks and valleys of YSB Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.33%
Maximum Annual PE Ratio = 114.48
Minimum Annual Increase = -12711.55%
Minimum Annual PE Ratio = -4.29
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 114.48 | -12711.55% |
| 2023 | -0.91 | -41.68% |
| 2022 | -1.56 | -63.74% |
| 2021 | -4.29 | 10.33% |
The current PE Ratio of YSB Inc. (9885.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
37.34
5-year avg
20.77
10-year avg
20.77
YSB Inc.’s PE Ratio is greater than LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (19.03), greater than Jenscare Scientific Co., Ltd. (-38.87), greater than Dingdang Health Technology Group Ltd. (-3.61), greater than Sunho Biologics, Inc. (-11.69), greater than Tianjin Construction Development Group Co., Ltd. (11.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| 19.03 | $6.02B | |
| -38.87 | $3.71B | |
| -3.61 | $1.38B | |
| -11.69 | $1.10B | |
| 11.00 | $140.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like YSB Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like YSB Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is YSB Inc.'s PE Ratio?
How is the PE Ratio calculated for YSB Inc. (9885.HK)?
What is the highest PE Ratio for YSB Inc. (9885.HK)?
What is the 3-year average PE Ratio for YSB Inc. (9885.HK)?
What is the 5-year average PE Ratio for YSB Inc. (9885.HK)?
How does the current PE Ratio for YSB Inc. (9885.HK) compare to its historical average?